LadRx Corporation
https://www.ladrxcorp.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From LadRx Corporation
Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE
Plus deals involving Novo Nordisk/Neomorph, Mabwell/Jiangsu Haibo, Alteogen/Merck & Co., Gilead/Biocytogen, AlphaGen/ARTBIO and XOMA/Kinnate.
Scrip Asks…What Does 2024 Hold For Biopharma? Part 4: Transformative Technology
More than 75 industry executives and experts gazed into the crystal ball and shared with Scrip their predictions around transformative technologies. Perhaps unsurprisingly, AI was the dominant theme – but gene editing, cell therapies and new targeting modalities were also among the highlights.
France's Pharnext Undone By Placebo Effect
The Paris-based biotech's Charcot-Marie-Tooth disease drug falls short in Phase III.
News We’re Watching: Quest And CDC Partner On Hep C, Califf on Clinical Trials, Latest Recalls And Approvals
This week, Quest Diagnostics contracted with the CDC to research the public health impact of hepatitis C; FDA Commissioner Robert Califf published a blog post on clinical trial transparency; Dexcom and Abbott approached a deal in their CGM patent case; and SoClean, Cordis and Eitan all announced recalls.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Large Molecule
- Other Names / Subsidiaries
-
- Centurion BioPharma
- Innovive Pharmaceuticals
- Zynaxis Inc.
- CytRx Corp.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice